-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Phio Pharmaceuticals Says US FDA Approves Clinical Trial With PH-762, AGX148 to Treat Solid Tumors

Phio Pharmaceuticals Says US FDA Approves Clinical Trial With PH-762, AGX148 to Treat Solid Tumors

MT Newswires · 01/06/2023 10:23